Tony Bowden – Chief Executive Officer

Tony was appointed Chief Executive Officer of Helicon Health in May 2015, having advised the Board on Strategy and Business Development for the preceding year.

He has over 30 years leadership experience in the Healthcare and Education technology sectors, during which time he founded and led two early stage businesses in the UK and Europe and acted as Business Development Director for Computer Science Corporation Healthcare division.

He has a wealth of experience in taking healthcare and education technology companies to highly successful exits with multi-national companies such as IBM, CSC and Discovery Communications.

Tony is a Partner at The IT Health Partnership, advising the NHS and suppliers to the NHS and private healthcare sectors in the drive towards joining up digital health and care. His early career was spent at Thorn Software where he developed and ran the London based vertical market division, for which he had full P&L responsibility across Healthcare, Public Sector and Financial Services.

Tony is an angel investor in a number of high growth start-ups. He is passionate about supporting SMEs and promoting their role in driving economic growth and prosperity.

Mark Gostock – Director

Mark brings over a decade of experience in strategic commercial direction and business mentoring across a multitude of technology sectors. Matched with significant expertise in healthcare commercialisation within industry and academia, Mark provides a critical and well-informed voice to the board of Helicon Health.

As Senior Business Manager with UCL-Business, Mark currently leads the translation and commercial exploitation of medtech and medical device technologies arising from research outputs at University College London.  Previous to this Mark delivered a similar program of technology transfer for the University of Oxford where he gained significant experience in licensing, spin-out creation and venture capital. Mark’s early career was spent with Farfield Group as Product Manager developing the company’s biosensor technology platform through collaboration with strategic networks formed in the pharma, biotech and biomedical sectors.  During his time with Farfield Group Mark spent several years in the U.S. building the company brand across North America.

Mark graduated with a BSc in Chemistry and MSc in Analytical Chemistry & Instrumentation before completing his PhD in Biophysics at the University of Nottingham.

Mark Leaning – Chairman

Mark is an engineer, innovator and entrepreneur with a passion for transforming healthcare for the better with technology. His work spans primary care to intensive care, from prevention to the critically ill and injured, and has led to large-scale market adoption, listings, acquisitions and the development of groundbreaking products.

In addition to his role as Chairman of Helicon, Mark is Founder of Directed Systems Ltd, which is developing autonomous care systems to improve safety and efficiency in intensive care and combat casualty care. Previously, as Executive Director at HCN, Australia’s leading supplier of clinical GP systems, Mark led the M&A program and played a key role in the company’s ASX listing. HCN subsequently realised $100m for its shareholders. Before HCN, while living in the United States, Mark was Chief Operating Officer of Preferred Health Systems, a medical software company he co-founded, which was acquired by Magellan Health Services.

Mark has an engineering degree from Cambridge University, followed by an MSc and PhD in Systems Engineering from City University. Mark was appointed a Visiting Professor at University College London in 2009 and is an advisor on Industry to the UCL Institute of Digital Health.

David Patterson MD, FRCP, FRSPH – Founder

David is Consultant Physician and Cardiologist based at Whittington Health. He is also Professor of Cardiovascular Medicine at UCL and the University of London and the only cardiovascular clinician in the UK actively involved in delivering a community focused anticoagulant and stroke prevention service.

David led his clinical department to achieve the Charter Mark over 12 years ago for the cardiology hospital ward and more recently played a lead role in the achievement of the new Customer Service Excellence standard, which was awarded for the hospital in-patient and out-patient services, together with the community delivered services across north central London.

For many years David was a Board member of the Service Development and Organisation (SDO), which is part of the National Institute of Health Research (NIHR). He has also served as a member of the Executive Group of the Central and East London NIHR Comprehensive Local Research Network.

His clinical interests include:

  • the prevention of coronary artery disease
  • the use of activity and exercise both in the prevention of, and in the treatment of cardiovascular disease
  • the development of new models of service delivery
  • the clinical governance of a “distributed clinical service”

Over recent years, in collaboration with CHIME (UCL Centre for Health Informatics and Multiprofessional Education) David has developed and evaluated clinical information systems, culminating in the clinically useful and secure EHR at the core of the HeliconHeart package.

David chairs The Institute of Sports and Exercise Medicine, a unique multi-professional Charity which helped to create the medical discipline of Sports and Exercise Medicine; it now concentrates on facilitating the development of research in these domains.